Collaboration & Strategy

Strategic
Partnerships

JCA Global works closely with scientific and biotechnology partners to ensure the responsible adoption of emerging regenerative technologies — with integrity, education, and long-term impact at the center of every collaboration.

Novatrail Partnership
Featured Partner

Novatrail, Inc.

Japan's Leading Regenerative Science Company

JCA Global maintains a strategic partnership with Novatrail, Inc., Japan's pioneering biotechnology company advancing cell-free regenerative medicine. Through this collaboration, JCA Global serves as a trusted bridge between Novatrail's scientific innovation and U.S. clinical and wellness markets.

Jaye Camposanto Andaya holds dual roles as Novatrail's Global Ambassador and U.S. Clinical Liaison — providing educational outreach, strategic market guidance, and direct relationship support with U.S.-based clinicians, practitioners, and distribution partners.

This partnership is grounded in shared values: scientific rigor, ethical communication, patient-centered outcomes, and a commitment to advancing regenerative medicine responsibly across borders.

Visit Novatrail
Focus Areas

How JCA Global Partners

Cell-Free Regenerative Technology

Supporting the responsible introduction of Japan's leading cell-free regenerative biotechnology to U.S. clinical and wellness markets through education, relationship-building, and ethical communication.

Cross-Border Collaboration

Bridging scientific innovation between Japan and the United States — facilitating dialogue, strategic alignment, and mutual understanding across cultures and regulatory environments.

Education & Scientific Communication

Developing clear, credible, and accessible educational frameworks for practitioners, patients, and industry stakeholders navigating the evolving landscape of regenerative medicine.

Strategic Partnership Development

Connecting regenerative biotechnology innovators with aligned clinical, wellness, and distribution partners in the United States — with attention to integrity, readiness, and long-term impact.

"The future of regenerative medicine will be built through trust — across borders, disciplines, and cultures. Partnership is not a strategy. It is the foundation."
— Jaye Camposanto Andaya, PA
Collaborate

Exploring a Partnership?

JCA Global welcomes conversations with biotech companies, researchers, clinicians, investors, and global health innovators aligned with responsible innovation in regenerative medicine.

Begin a Conversation